APA (7th ed.) Citation

W, K., P, G., KB, D., HN, N., S, S., AS, F., . . . DJ, M. (2024). Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 10(4), e70020. https://doi.org/10.1002/trc2.70020

Chicago Style (17th ed.) Citation

W, Kielbasa, et al. "Discovery and Clinical Translation of Ceperognastat, an O-GlcNAcase (OGA) Inhibitor, for the Treatment of Alzheimer's Disease." Alzheimer's & Dementia (New York, N. Y.) 10, no. 4 (2024): e70020. https://doi.org/10.1002/trc2.70020.

MLA (9th ed.) Citation

W, Kielbasa, et al. "Discovery and Clinical Translation of Ceperognastat, an O-GlcNAcase (OGA) Inhibitor, for the Treatment of Alzheimer's Disease." Alzheimer's & Dementia (New York, N. Y.), vol. 10, no. 4, 2024, p. e70020, https://doi.org/10.1002/trc2.70020.